Egr-1 for the preparation of a medicament for treating wounds.

Use of a nucleic acid molecule comprising a sequence encoding a polypeptide transcription factor Egr-1 or a biologically active fragment thereof in the manufacture of a medicament for the treatment of wounds in a mammal, including humans.